49 / 68
(3)
In accordance with the SEC's reporting requirements, we report all equity awards at their full grant date fair value in accordance with ASC 718. The Company's valuation
assumptions are described in Note 12 “Share-Based Compensation” in the Notes to the Consolidated Financial Statements in the Company’s Annual Form 10-K filed with
the SEC for the year ended December 31, 2014. See page 47 for a more detailed discussion of our outstanding equity grants compared to current fair market value.
As discussed in the “Determination of CEO Compensation” section of the CD&A, the Compensation Committee reduced the contingent February 2014 PBRS grant for
Daniel P. Amos by 56,134 shares on December 31, 2014 after the 2014 performance of the Company was validated. The remaining 34,308 shares had a grant date fair
market value of $2,141,162. Additionally, the Compensation Committee reduced the contingent February 2012 PBRS grant for Daniel P. Amos by 60,343 shares in August
of 2012 after the 2011 performance of the Company was validated. The remaining 91,813 shares had a grant date fair market value of $4,458,439.
(4)
The amount reported in this column for Mr. Tonoike has two components. Mr. Tonoike’s earned bonus is paid one-half in cash and the other half is increased by 10% and
deferred until his retirement date. The total amount has been included in the Summary Compensation Table and the deferred amount, including the 10% addition, has been
included in the 2014 Nonqualified Deferred Compensation table below.
(5)
No amount in this column is attributable to above market earnings on deferred compensation. The change in pension value was driven largely by the adoption of the
updated mortality tables (RP-14) released by the Society of Actuaries in October 2014. The tables increased life expectancy for both males and females. See the “Pension
Benefits” section and the accompanying table below beginning on page 50 for a more detailed discussion of the retirement plans.
(6)
Additional information regarding all other compensation is provided in the “All Other Compensation” or “Perquisites” tables detailed below.
(7)
Base salary is typically the smallest component of total compensation for the NEOs as the majority of their total compensation is based on performance awards on a cash
and equity basis. Base salaries (including deferrals) as a percent of total compensation for Messrs. Daniel P. Amos, Cloninger, Paul S. Amos II, Kirsch and Tonoike for
2014 were approximately 9%, 11%, 11%, 15%, and 21%, respectively.
45